Hertig A - Search Results

1

Candida albicans arteritis transmitted by conservative liquid after renal transplantation: a report of four cases and review of the literature.

Mai H, Champion L, Ouali N, Hertig A, Peraldi MN, Glotz D, Rondeau E, Costa MA, Snanoudj R, Benoit G, Charpentier B, Durrbach A. Mai H, et al. Among authors: hertig a. Transplantation. 2006 Nov 15;82(9):1163-7. doi: 10.1097/01.tp.0000239188.27153.23. Transplantation. 2006. PMID: 17102767 Review.

2

Acute cortical necrosis in acquired immunodeficiency syndrome (AIDS).

Hertig A, Couprie R, Haymann JP, Mougenot B, Farres N, Peraldi MN, Rondeau E, Sraer JD. Hertig A, et al. Nephrol Dial Transplant. 1997 Mar;12(3):585-7. doi: 10.1093/ndt/12.3.585. Nephrol Dial Transplant. 1997. PMID: 9075148 No abstract available.

3

Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis.

Rerolle JP, Hertig A, Nguyen G, Sraer JD, Rondeau EP. Rerolle JP, et al. Among authors: hertig a. Kidney Int. 2000 Nov;58(5):1841-50. doi: 10.1111/j.1523-1755.2000.00355.x. Kidney Int. 2000. PMID: 11044203 Free article. Review.

4

[Plasminogen activator inhibitor type 1: physiology and role in renal physiopathology].

Rerolle JP, Vigneau C, Hertig A, Berrou J, Rondeau E. Rerolle JP, et al. Among authors: hertig a. Nephrologie. 2001;22(1):5-13. Nephrologie. 2001. PMID: 11280040 Review. French.

5

Prognostic value of plasminogen activator inhibitor type 1 mRNA in microdissected glomeruli from transplanted kidneys.

Delarue F, Hertig A, Alberti C, Vigneau C, Ammor M, Berrou J, Akposso K, Peraldi MN, Rondeau E, Sraer JD. Delarue F, et al. Among authors: hertig a. Transplantation. 2001 Oct 15;72(7):1256-61. doi: 10.1097/00007890-200110150-00013. Transplantation. 2001. PMID: 11602852

6

Chronic graft dysfunction in renal transplant patients: potential role of plasminogen activator inhibitor type 1.

Lahlou A, Peraldi MN, Thervet E, Flahault A, Delarue F, Soubrier F, Rossert J, Hertig A, Rondeau E. Lahlou A, et al. Among authors: hertig a. Transplantation. 2002 Apr 27;73(8):1290-5. doi: 10.1097/00007890-200204270-00018. Transplantation. 2002. PMID: 11981424

7

Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta.

Hertig A, Berrou J, Allory Y, Breton L, Commo F, Costa De Beauregard MA, Carmeliet P, Rondeau E. Hertig A, et al. FASEB J. 2003 Oct;17(13):1904-6. doi: 10.1096/fj.03-0084fje. Epub 2003 Aug 1. FASEB J. 2003. PMID: 12897066

8

Mechanisms of intraglomerular coagulation.

Hertig A, Rondeau E. Hertig A, et al. Nefrologia. 2003;23 Suppl 3:21-4. Nefrologia. 2003. PMID: 12901187 Free article. Review. No abstract available.

9

Role of the coagulation/fibrinolysis system in fibrin-associated glomerular injury.

Hertig A, Rondeau E. Hertig A, et al. J Am Soc Nephrol. 2004 Apr;15(4):844-53. doi: 10.1097/01.asn.0000115400.52705.83. J Am Soc Nephrol. 2004. PMID: 15034086 Review.

10

Plasminogen activator inhibitor type 1: the two faces of the same coin.

Hertig A, Rondeau E. Hertig A, et al. Curr Opin Nephrol Hypertens. 2004 Jan;13(1):39-44. doi: 10.1097/00041552-200401000-00006. Curr Opin Nephrol Hypertens. 2004. PMID: 15090858 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters